dbACP: A Comprehensive Database of Anti-Cancer Peptides

29 result(s) have been found!

Accession Name Sequence Source/Organism Mechanism Assay Type Cell Line Cancer Type Activity
dbacp00821 AaeAP1 FLFSLIPSVIAGLVSAIRN Venom, Aeneas fattailed scorpion, Africa Membrane lysis MTT assay NCI-H460 Human lung adenocarcinoma MIC : 10−4 to 10−9 M
dbacp00822 AaeAP1 FLFSLIPSVIAGLVSAIRN Venom, Aeneas fattailed scorpion, Africa Membrane lysis MTT assay MB435s Human breast carcinoma MIC : 10−4 to 10−9 M
dbacp00823 AaeAP1 FLFSLIPSVIAGLVSAIRN Venom, Aeneas fattailed scorpion, Africa Membrane lysis MTT assay MCF-7 Non-tumourigenic mammary gland cancer MIC : 10−4 to 10−9 M
dbacp00824 AaeAP1 FLFSLIPSVIAGLVSAIRN Venom, Aeneas fattailed scorpion, Africa Membrane lysis MTT assay PC-3 Human prostate carcinoma MIC : 10−4 to 10−9 M
dbacp00829 AaeAP2 FLFSLIPSAIAGLVSAIRN Venom, Aeneas fattailed scorpion, Africa Membrane lysis MTT assay NCI-H460 Human lung adenocarcinoma MIC : 10−4 to 10−9 M
dbacp00830 AaeAP2 FLFSLIPSAIAGLVSAIRN Venom, Aeneas fattailed scorpion, Africa Membrane lysis MTT assay MB435s Human breast carcinoma MIC : 10−4 to 10−9 M
dbacp00831 AaeAP2 FLFSLIPSAIAGLVSAIRN Venom, Aeneas fattailed scorpion, Africa Membrane lysis MTT assay MCF-7 Non-tumourigenic mammary gland cancer MIC : 10−4 to 10−9 M
dbacp00832 AaeAP2 FLFSLIPSAIAGLVSAIRN Venom, Aeneas fattailed scorpion, Africa Membrane lysis MTT assay PC-3 Human prostate carcinoma MIC : 10−4 to 10−9 M
dbacp02659 Dermaseptin-B3 ALWKnMLKGIGKLAGQAALGAVKTLVGAE Giant leaf frog Membrane lysis In vitro proliferation assay, Soft agar assay PC-3 Human epithelial prostate adenocarcinoma EC50 : 2 μM
dbacp02779 Distinctin-Like-Peptide-PH NLVSALIEGRKYLKNVLKKLNRLKEKNKAKNSKENN Skin Secretion, Northern orange-legged leaf frog, South America Membrane lysis via pore formation MTT Cell viability assay, LDH assay H157 Prostate carcinoma MIC : ≥ 4.197 μM
dbacp02780 Distinctin-Like-Peptide-PH NLVSALIEGRKYLKNVLKKLNRLKEKNKAKNSKENN Skin Secretion, Northern orange-legged leaf frog, South America Membrane lysis via pore formation MTT Cell viability assay, LDH assay H158 Prostate carcinoma IC50 : 15.41 μg/mL
dbacp02781 Distinctin-Like-Peptide-PH NLVSALIEGRKYLKNVLKKLNRLKEKNKAKNSKENN Skin Secretion, Northern orange-legged leaf frog, South America Membrane lysis via pore formation MTT Cell viability assay, LDH assay PC3 Lung cancer MIC : ≥ 4.197 μM
dbacp02782 Distinctin-Like-Peptide-PH NLVSALIEGRKYLKNVLKKLNRLKEKNKAKNSKENN Skin Secretion, Northern orange-legged leaf frog, South America Membrane lysis via pore formation MTT Cell viability assay, LDH assay PC3 Lung cancer IC50 : 32.25 μg/mL
dbacp02826 EGFR-lytic YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK Synthetic Peptide Cell membrane lysis ELISA MDA-MB-231 Breast cancer IC50 : 0.12 µM
dbacp02827 EGFR-lytic YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK Synthetic Peptide Cell membrane lysis ELISA MDA-MB-231 Breast cancer IC50 : 0.46 µM
dbacp04592 Mauriporin MNKKTLLVIFFITMLIVDEVNSFKIGGFIKKLWRSKLAKKLRAKGRELLKDYANRVINGGPEEEAAVPAERRR Fat-tailed scorpion Induce cell apoptosis; Targets on the cell membranes and caused membrane lysis MTT assay, Lactate dehydrogenase (LDH) Release assay Hela Human cervical cancer IC50 : 27.9 μM - 283.3 μM
dbacp04593 Mauriporin MNKKTLLVIFFITMLIVDEVNSFKIGGFIKKLWRSKLAKKLRAKGRELLKDYANRVINGGPEEEAAVPAERRR Fat-tailed scorpion Induce cell apoptosis; Targets on the cell membranes and caused membrane lysis MTT assay, Lactate dehydrogenase (LDH) Release assay SACC-83 Human salivary adenoid cystic carcinoma IC50 : 27.9 μM - 283.3 μM
dbacp04594 Mauriporin MNKKTLLVIFFITMLIVDEVNSFKIGGFIKKLWRSKLAKKLRAKGRELLKDYANRVINGGPEEEAAVPAERRR Fat-tailed scorpion Induce cell apoptosis; Targets on the cell membranes and caused membrane lysis MTT assay, Lactate dehydrogenase (LDH) Release assay HepG2 Human liver cancer IC50 : 27.9 μM - 283.3 μM
dbacp04595 Mauriporin MNKKTLLVIFFITMLIVDEVNSFKIGGFIKKLWRSKLAKKLRAKGRELLKDYANRVINGGPEEEAAVPAERRR Fat-tailed scorpion Induce cell apoptosis; Targets on the cell membranes and caused membrane lysis MTT assay, Lactate dehydrogenase (LDH) Release assay PC-3 Human Prostate cancer IC50 : 27.9 μM - 283.3 μM
dbacp06737 Aurein 1.2_mutant (Aurm) GLFDIIKKIIKSF Synthetic Necrotic activity via cell membrane lysis and apoptotic activity through disrupting mitochondrial membrane MTT assay SW-480 Colon Cancer 51.63% cell viability
dbacp06738 Aurein 1.2_mutant (Aurm) GLFDIIKKIIKSF Synthetic Necrotic activity via cell membrane lysis and apoptotic activity through disrupting mitochondrial membrane MTT assay HT-29 Colon Cancer 66.10% cell viability
dbacp06739 Aurein 1.2_R5 (R5-Aur) RRRRRGLFDIIKKIAESF Synthetic Necrotic activity via cell membrane lysis and apoptotic activity through disrupting mitochondrial membrane MTT assay SW-480 Colon Cancer 43.89% cell viability
dbacp06740 Aurein 1.2_R5 (R5-Aur) RRRRRGLFDIIKKIAESF Synthetic Necrotic activity via cell membrane lysis and apoptotic activity through disrupting mitochondrial membrane MTT assay HT-29 Colon Cancer 61.56% cell viability
dbacp06741 Aurein 1.2_mutant_R5 (R5-Aurm) RRRRRGLFDIIKKIIKSF Synthetic Necrotic activity via cell membrane lysis and apoptotic activity through disrupting mitochondrial membrane MTT assay SW-480 Colon Cancer 40.62% cell viability
dbacp06742 Aurein 1.2_mutant_R5 (R5-Aurm) RRRRRGLFDIIKKIIKSF Synthetic Necrotic activity via cell membrane lysis and apoptotic activity through disrupting mitochondrial membrane MTT assay HT-29 Colon Cancer 54.22% cell viability
dbacp07339 D-melittin gigavlkvlttglpaliswikrkrqqc Synthetic pH-triggered release, membrane lysis, immunogenic death MTS assay A-549 Lung Cancer IC50 = 4.5 µM
dbacp07340 D-melittin gigavlkvlttglpaliswikrkrqqc Synthetic pH-triggered release, membrane lysis, immunogenic death MTS assay CT-26 Colorectal Cancer IC50 = 2.2 µM
dbacp07341 D-melittin gigavlkvlttglpaliswikrkrqqc Synthetic pH-triggered release, membrane lysis, immunogenic death MTS assay MDA-MB-435 WT Breast Cancer IC50 = 3.5 µM
dbacp07342 D-melittin gigavlkvlttglpaliswikrkrqqc Synthetic pH-triggered release, membrane lysis, immunogenic death MTS assay MDA-MB-435 DOX-R Breast Cancer IC50 = 3.4 µM